These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24094236)

  • 1. Hemolytic disease of the fetus and newborn owing to anti-U, successfully treated with repeated intrauterine transfusions.
    Strindberg J; Lundahl J; Ajne G
    Immunohematology; 2013; 29(2):51-4. PubMed ID: 24094236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
    Sainio S; Nupponen I; Kuosmanen M; Aitokallio-Tallberg A; Ekholm E; Halmesmäki E; Orden MR; Palo P; Raudaskoski T; Tekay A; Tuimala J; Uotila J; Stefanovic V
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
    Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
    Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Jordanian family with three sisters apparently homozygous for M
    Al-Jada NA
    Transfusion; 2017 Feb; 57(2):376-378. PubMed ID: 27807866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku.
    Lydaki E; Nikoloudi I; Kaminopetros P; Bolonaki I; Sifakis S; Kikidi K; Koumantakis E; Foundouli K
    Transfusion; 2005 Nov; 45(11):1791-5. PubMed ID: 16271105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
    Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
    Delaney M; Matthews DC
    Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
    Moise KJ; Ling LE; Oepkes D; Tiblad E; Verweij EJTJ; Lopriore E; Smoleniec J; Sachs UJ; Bein G; Kilby MD; Miller RS; Devlieger R; Audibert F; Emery SP; Markham K; Norton ME; Ocón-Hernández O; Pandya P; Pereira L; Silver RM; Windrim R; Streisand JB; Leu JH; Mirza A; Smith V; Schwartz LB; Tjoa ML; Saeed-Khawaja S; Komatsu Y; Bussel JB;
    N Engl J Med; 2024 Aug; 391(6):526-537. PubMed ID: 39115062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
    Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
    Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasis.
    Macher S; Wagner T; Rosskopf K; Reiterer F; Csapo B; Schlenke P; Klaritsch P
    Transfusion; 2016 Jan; 56(1):80-3. PubMed ID: 26496681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of Villous Immaturity in Term Deliveries Following Intrauterine Transfusion for Parvovirus B19 Infection and RhD-associated Hemolytic Disease of the Fetus and Newborn.
    McCarthy WA; Popek EJ
    Pediatr Dev Pathol; 2017; 20(6):469-474. PubMed ID: 29187036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of intrauterine transfusion on fetal coagulation physiology by thromboelastography.
    Emery SP; Lopa S; Waters JH
    Prenat Diagn; 2020 Apr; 40(5):585-589. PubMed ID: 31994748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemolytic disease of the newborn. Prenatal diagnosis, prognosis and intrauterine transfusion in the severely diseased fetus].
    Maroni E; Schreiner WE
    Med Klin; 1969 Mar; 64(13):569-78. PubMed ID: 4891636
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
    Al Riyami AZ; Al Salmani M; Al Hashami S; Al Mahrooqi S; Al Hinai S; Al Balushi H; Al Riyami N; Gowri V; Al Dughaishi T; Al Hosni S; Al-Khabori M; Al-Farsi K; Al Huneini M; Alkindi S
    Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intrauterine blood transfusion: Status report of 4years of practice in France (2011-2014)].
    Girault A; Friszer S; Maisonneuve E; Guilbaud L; Cortey A; Jouannic JM
    J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):119-124. PubMed ID: 28403966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
    Andersen LH; Jacob EK; McThenia SS; Tauscher CD; Patterson ER; Oliveira JL; Rodriguez V
    Transfusion; 2021 Mar; 61(3):974-978. PubMed ID: 33444461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.
    Verduin EP; Brand A; van de Watering LM; Claas FH; Oepkes D; Lopriore E; Doxiadis II; Schonewille H
    Br J Haematol; 2015 Feb; 168(3):443-51. PubMed ID: 25244566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDFN Resulting from Anti-U: Alternatives to Allogeneic Intrauterine Transfusion.
    Caudill JL; Gillard L
    Lab Med; 2022 Jul; 53(4):e79-e82. PubMed ID: 34791347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.